Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 7Terminated 5Recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 5Vincristine 4Doxorubicin 3fludarabine phosphate 2Psychiatric Rehabilitation 2Prednisone 2Prednisolone 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Flow Cytometry 2Etoposide 2Cytarabine 2Cyclosporine 2Busulfan 2Antilymphocyte Serum 2Alemtuzumab 2sargramostim 1ruxolitinib 1nelarabine 1motesanib diphosphate 1carbendazim 1Transplantation 1Therapeutics 1Steroids 1Sensitivity and Specificity 1S-1,2-dichlorovinyl-N-acetylcysteine 1Ritonavir 1Radiotherapy 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × nelarabine × Clear all
NCT06434467 2024-05-30

The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 3 Unknown
83 enrolled
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡